Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 166, Issue 4, Pages 1303-1319
Publisher
Wiley
Online
2012-01-06
DOI
10.1111/j.1476-5381.2012.01825.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR
- (2011) Ana M. Briones et al. Journal of the American Society of Hypertension
- Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats
- (2010) Xiao Lu et al. Cardiovascular Diabetology
- Oral Intake of Rosiglitazone Promotes a Central Antihypertensive Effect Via Upregulation of Peroxisome Proliferator-Activated Receptor-γ and Alleviation of Oxidative Stress in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats
- (2010) Samuel H.H. Chan et al. HYPERTENSION
- Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension
- (2010) Lili Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPARγ Activation Prevents Hypertensive Remodeling of Cerebral Arteries and Improves Vascular Function in Female Rats
- (2010) Marilyn J. Cipolla et al. STROKE
- Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors
- (2009) Michel Félétou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vascular insulin resistance in prehypertensive rats: Role of PI3-kinase/Akt/eNOS signaling
- (2009) Rong Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Atorvastatin Prevents Endothelial Dysfunction in Mesenteric Arteries From Spontaneously Hypertensive Rats
- (2009) Agostino Virdis et al. HYPERTENSION
- Fenofibrate and Pioglitazone Do Not Ameliorate the Altered Vascular Reactivity in Aorta of Isoproterenol-treated Rats
- (2009) Lívia Emy Fukuda et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats
- (2009) Ana B García-Redondo et al. JOURNAL OF HYPERTENSION
- Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats
- (2008) Elodie Gomez et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Troglitazone Increases IL-1β Induced Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression via Enhanced Phosphorylation of IκBα in Vascular Smooth Muscle Cells from Wistar-Kyoto Rats and Spontaneously Hypertensive Rats
- (2008) Young Jin Kang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2and prostacyclin
- (2008) F E Xavier et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: Are the reagents beneficial or harmful?
- (2008) Rui Chen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats
- (2007) Y Álvarez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant
- (2007) Sabine Heumüller et al. HYPERTENSION
- Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension
- (2007) Eva H. C. Tang et al. PHYSIOLOGICAL GENOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started